基于多胺转运系统的抗肿瘤药物研究进展

doi:10.13560/j.cnki.biotech.bull.1985.2017.05.005

生物技术通报 ›› 2017, Vol. 33 ›› Issue (5): 34-39.doi: 10.13560/j.cnki.biotech.bull.1985.2017.05.005

基于多胺转运系统的抗肿瘤药物研究进展

李建明，丁劲松

中南大学湘雅药学院,长沙 410013

收稿日期:2016-09-23 出版日期:2017-05-25 发布日期:2017-05-19
作者简介:李建明,男,硕士研究生,研究方向：药物传递系统与新药给药系统;E-mail：ming199203@sina.com
基金资助:
国家自然科学基金资助项目（81603061,81573374）,中南大学研究生自主探索创新基金资助项目（2016zzts495）

Drug Research in Cancer Therapy Based on Polyamine Transport System

LI Jian-ming DING Jin-song

Xiangya School of Pharmaceutical Sciences,Central South University,Changsha 410013

Received:2016-09-23 Published:2017-05-25 Online:2017-05-19

摘要/Abstract

摘要： 多胺是维持细胞生长分化等生命活动的必需物质。肿瘤的增殖与细胞内多胺水平密切相关,利用肿瘤细胞膜表面高表达的多胺转运系统介导多胺类似物和缀合物进入细胞,可耗竭细胞内多胺并诱导肿瘤细胞凋亡。也可利用多胺聚阳离子的结构特点进行基因递送,提高外源基因的转染效率。综述了基于多胺转运系统的多胺类似物,缀合物和基因递送的癌症治疗研究进展,旨为以多胺结构为基础的抗肿瘤药物研究提供参考。

关键词: 多胺转运系统, 多胺类似物, 多胺缀合物, 肿瘤靶向, 基因递送

Abstract: Polyamine is an essential substance in cells growth,differentiation and other life activities. The proliferation of tumor is closely related to the level of intracellular polyamine. Delivering polyamine analogs and conjugates into cells,mediated by polyamine transport system overexpressed on tumor cell surface,leads to the exhaustion of intracellular polyamine and then induces tumor cells apoptosis. In addition,using the positive structure characteristics of polyamine to deliver therapeutic genes may increase the transfection efficiency of exogenous genes. In order to provide reference for the research of anticancer agents based on polyamine in the future,the research progress on polyamine analogues and conjugates for treating cancer and using polyamine as a gene deliver vector are summarized here.

Key words: polyamine transport system, polyamine analogues, polyamine conjugates, tumor targeting, gene delivery

李建明，丁劲松. 基于多胺转运系统的抗肿瘤药物研究进展[J]. 生物技术通报, 2017, 33(5): 34-39.

LI Jian-ming DING Jin-song. Drug Research in Cancer Therapy Based on Polyamine Transport System[J]. Biotechnology Bulletin, 2017, 33(5): 34-39.

参考文献

[1] Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism[J]. Biochemical Journal, 2003, 376（1）：1-14.
[2] Nowotarski SL, Woster PM, Jr CR. Polyamines and cancer：implications for chemotherapy and chemoprevention[J]. Expert Reviews in Molecular Medicine, 2013, 15（3）：139-147.
[3] Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines[J]. Int J Biochem Cell Biol, 2010, 42（1）：39-51.
[4] Minois N, Carmonagutierrez D, Madeo F. Polyamines in aging and disease[J]. Aging, 2011, 3（8）：716-732.
[5] Moinard C, Cynober L, Bandt JPD. Polyamines：metabolism and implications in human diseases[J]. Clin Nutr, 2005, 2：184-197.
[6] Gardner RA, Delcros JG, et al. N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polya-mine transporters[J]. J Med Chem, 2004（24）：6055-6069.
[7] Wang C, Delcros JG, Biggerstaff J. Synthesis and biological evaluation of N1-（anthracen-9-ylmethyl）triamines as molecular recognition elements for the polyamine transporter[J]. Journal of Medicinal Chemistry, 2003, 46（13）：2663-2671.
[8] Jr CR, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases[J]. Dressnature Reviews Drug Discovery, 2007, 6（5）：373-390.
[9] Thomas TJ, Tajmir-Riahi HA, Thomas T. Polyamine-DNA interactions and development of gene delivery vehicles[J]. Amino Acids, 2016, 48（10）：2423-2431.
[10] Wallace HM, Fraser AV. Polyamine analogues as anticancer drugs[J]. Biochem Soc Trans, 2003, 31（2）：393-396.
[11] Silva TM, Fiuza SM, et al. Increased breast cancer cell toxicity by palladination of the polyamine analogue N 1, N 11-bis（ethyl）norspermine[J]. Amino Acids, 2014, 46（2）：339-352.
[12] Casero RA Jr, Woster PM. Recent advances in the development of polyamine analogues as antitumor agents[J]. Journal of Medicinal Chemistry, 2009, 52（15）：4551-4573.
[13] Casero RA Jr, Woster PM. Terminally alkylated polyamine analogues as chemotherapeutic agents[J]. Journal of Medicinal Chemistry, 2001, 44（1）：1-26.
[14] Valasinas A, Sarkar A, Reddy VK, et al. Conformationally restricted analogues of 1N, 14N-bisethylhomospermine（BE-4-4-4）：synthesis and growth inhibitory effects on human prostate cancer cells[J]. J Med Chem, 2001, 44（3）：390-403.
[15] Mitchell JL, Leyser A, Holtorff MS, et al. Antizyme induction by polyamine analogues as a factor of cell growth inhibition[J]. Biochemical Journal, 2002, 366（2）：663-671.
[16] Huang Y, et al. Molecular mechanisms of polyamine analogs in cancer cells[J]. Anti-Cancer Drugs, 2005, 16（3）：229-241.
[17] Boncher T, Bi X, Varghese S, et al. Polyamine-based analogues as biochemical probes and potential therapeutics[J]. Biochemical Society Transactions, 2007, 35（2）：356-363.
[18] 罗稳, 李展, 翟洋洋, 等. 萘酰亚胺多胺衍生物的合成及其抗肿瘤活性[J]. 应用化学, 2013, 30（3）：265-270.
[19] 刘英杰, 等. 一种萘酰亚胺-多胺缀合物对人肝癌HepG2细胞的杀伤作用[J]. 中国药学杂志, 2016（3）：207-212.
[20] 田智勇, 苏雷朋, 谢松强, 等. 萘酰亚胺-多胺缀合物的合成、生物活性和荧光光谱[J]. 有机化学, 2013（7）：1514-1521.
[21] Rui T, Ghani RA, Phanstiel O, et al. Ant 4, 4, a polyamine-anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells（HL-60）[J]. Amino Acids, 2013, 44（4）：1193-1203.
[22] Sarrazy V, Garcia G, et al. Photodynamic effects of porphyrin-polyamine conjugates in human breast cancer and keratinocyte cell lines[J]. J Photochem Photobiol B, 2011, 103（3）：201-206.
[23] Tomasi S, Renault J, Martin B, et al. Targeting the polyamine transport system with benzazepine- and azepine-polyamine conjugates[J]. J Med Chem, 2010, 53（21）：7647-7663.
[24] Mouawad F, Gros A, et al. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines[J]. Oral Oncol, 2014（2）：113-119.
[25] 许晓辉, 孙陶利, 许莉莉, 等. 鬼臼毒素类新药的研发思路[J]. 转化医学杂志, 2014, 3（3）：162-165.
[26] Thibault B, Clement E, Zorza G, et al. F14512, a polyamine-vector-ized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer[J]. Cancer Lett, 2016（1）：10-18.
[27] Samorì C, et al. The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugates[J]. Bioconjug Chemi, 2008, 19（11）：2270-2279.
[28] Vijayanathan V, Agostinelli E, et al. Innovative approaches to the use of polyamines for DNA nanoparticle preparation for gene therapy[J]. Amino Acids, 2014, 46（3）：499-509.
[29] Thomas RM, Thomas T, Wada M, et al. Facilitation of the cellular uptake of a triplex-forming oligonucleotide by novel polyamine analogues：structure-activity relationships[J]. Biochemistry, 1999, 38（40）：13328-13337.
[30] Nayvelt I, et al. DNA condensation by chiral alpha-methylated polyamine analogues and protection of cellular DNA from oxidative damage[J]. Biomacromolecules, 2010, 11（1）：97-105.
[31] Zhu Y, Li J, Kanvinde S, et al. Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer[J]. Molecular Pharmaceutics, 2014, 12（2）：555-563.
[32] Dewa T, Asai T, Tsunoda Y, et al. Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers：chemical structure, morphology, and gene transfer activity[J]. Bioconjugate Chemistry, 2010, 21（5）：844-852.
[33] Jiang H, Lim H, Kim Y, et al. Chitosan-graft-spermine as a gene carrier in vitro and in vivo[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2011, 77（1）：36-42.
[34] Cui PF, Xing L, et al. Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer[J]. Int J Pharm, 2016, 506（1-2）：79-86.
[35] Sanyakamdhorn S, Chanphai P, et al. Encapsulation of biogenic and synthetic polyamines by nanoparticles PEG and mPEG-anthracene[J]. J Photochem Photobiol B, 2014, 130（1）：30-39.
[36] Mandeville JS, Bourassa P, Thomas TJ, et al. Biogenic and synthetic polyamines bind cationic dendrimers[J]. PLoS One, 2012, 7（4）：2010-2026.
[37] Chanphai P, Tajmir-Riahi HA. Thermodynamic analysis of biogenic and synthetic polyamines conjugation with PAMAM-G4 nanoparticles[J]. J Photochem Photobiol B, 2015, 155：13-19.

基于多胺转运系统的抗肿瘤药物研究进展

Drug Research in Cancer Therapy Based on Polyamine Transport System

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	姚琳通, 刘娅婷, 刘雅静, 陈真真. 介孔二氧化硅在肿瘤治疗领域的研究进展[J]. 生物技术通报, 2019, 35(2): 182-191.
[2]	马容, 陈咨余, 姜冬梅, 康波. 多胺在癌症治疗中的作用及机制[J]. 生物技术通报, 2016, 32(2): 46-50.
[3]	周培杰,高维强,方煜翔. 一种嵌合型调控元件在肿瘤靶向基因治疗中的应用[J]. 生物技术通报, 2015, 31(10): 255-262.